Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.21 +0.06 (+4.78%)
As of: Oct 22, 2026 · 9:49 AM EDT

Chemomab Therapeutics (CMMB) Other Operating Expenses (2019 - 2020)

Updated

Chemomab Therapeutics (CMMB) recorded Other Operating Expenses of $1.7 million in FY2021, up 104.7% from $828,000 in FY2020.

Analysis

Chemomab Therapeutics (CMMB) Other Operating Expenses (2019 - 2020) Analysis & Trends

  • Per Business Quant data, CMMB's Other Operating Expenses was $828,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,164.86 Bn 1,133.45 Bn 19.71 Bn
2 Johnson & Johnson 632.18 Bn 550.71 Bn 17.26 Bn
3 AbbVie 503.53 Bn 476.64 Bn 12.70 Bn
4 Merck 378.03 Bn 332.41 Bn 12.21 Bn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn
6 Astrazeneca 266.38 Bn 240.07 Bn 12.86 Bn
7 Amgen 241.24 Bn 196.64 Bn 7.24 Bn
8 Gilead Sciences 193.68 Bn 167.88 Bn 6.22 Bn
9 Pfizer 172.22 Bn 118.87 Bn 10.94 Bn
10 Chemomab Therapeutics 7.69 Mn -27.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -79,000.00
Mar 31, 2020 -670,000.00
Dec 31, 2019 3.35 Mn
API Access

Chemomab Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=CMMB&period=max&api_key=YOUR_API_KEY